{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:52:18Z","timestamp":1793332338273,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Evidence-Based Research Special Project for the Construction of High-Level Traditional Chinese Medicine Hospitals of Wangjing Hospital, China Academy of Chinese Medical Sciences","award":["WJYY-XZKT-2023-14"],"award-info":[{"award-number":["WJYY-XZKT-2023-14"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08093-2","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:28:11Z","timestamp":1775575691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term enoxaparin use and osteoporosis risk: a real-world cohort study with integrative computational and network toxicology approaches"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhen-Jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"8093_CR1","doi-asserted-by":"crossref","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet (London, England). 2019;393(10169):364\u2009\u2013\u200976.","DOI":"10.1016\/S0140-6736(18)32112-3"},{"key":"8093_CR2","unstructured":"GBD LBMD. The global, regional, and national burden attributable to low bone mineral density, 1990\u20132020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatol. 2025;7(12):e873\u201394."},{"key":"8093_CR3","doi-asserted-by":"crossref","unstructured":"Liang H, Chen S, Shi M, Xu J, Zhao C, Yang B, et al. Global epidemiology and burden of osteoporosis among postmenopausal women: insights from the Global Burden of Disease Study 2021. npj Aging. 2025;11(1):78.","DOI":"10.1038\/s41514-025-00269-2"},{"key":"8093_CR4","doi-asserted-by":"crossref","unstructured":"Kanis JA, Cooper C, Rizzoli R, Reginster J, Scientific ABOT. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2019;30(1):3\u201344.","DOI":"10.1007\/s00198-018-4704-5"},{"key":"8093_CR5","doi-asserted-by":"crossref","unstructured":"Hoong CWS, Saul D, Khosla S, Sfeir JG. Advances in the management of osteoporosis. BMJ (Clinical research ed.). 2025;390:e81250.","DOI":"10.1136\/bmj-2024-081250"},{"key":"8093_CR6","doi-asserted-by":"crossref","unstructured":"Tai T, Tsai Y, Shih C, Li C, Chang Y, Huang C, et al. Refracture risk and all-cause mortality after vertebral fragility fractures: anti-osteoporotic medications matter. J Formos Med Assoc. 2023;122 Suppl 1:S65\u201373.","DOI":"10.1016\/j.jfma.2023.04.004"},{"key":"8093_CR7","doi-asserted-by":"crossref","unstructured":"Nasser MI, Burton A, Wilson H, Manyanga T, Madanhire T, Mushayavanhu P, et al. Impact of hip fracture on survival, disability, pain, and health-related quality of life in Zimbabwe: a prospective cohort study. Lancet Healthy Longev. 2025;6(9):100766.","DOI":"10.1016\/j.lanhl.2025.100766"},{"key":"8093_CR8","doi-asserted-by":"crossref","unstructured":"Wang L, Chen L, Chen K. Hormone-related and drug-induced osteoporosis: a cellular and molecular overview. Int J Mol Sci. 2023;24(6):5814.","DOI":"10.3390\/ijms24065814"},{"key":"8093_CR9","doi-asserted-by":"crossref","unstructured":"Smit AE, Meijer OC, Winter EM. The multi-faceted nature of age-associated osteoporosis. Bone Rep. 2024;20:101750.","DOI":"10.1016\/j.bonr.2024.101750"},{"key":"8093_CR10","doi-asserted-by":"crossref","unstructured":"Song X, Zhang Y, Yang H, Xiong F, Chen F. Advances in the study and treatment of glucocorticoid osteoporosis: a review. Medicine. 2025;104(22):e42668.","DOI":"10.1097\/MD.0000000000042668"},{"issue":"6","key":"8093_CR11","doi-asserted-by":"publisher","first-page":"151480","DOI":"10.1016\/j.semnephrol.2023.151480","volume":"2023\/11\/1","author":"B Stegmayr","year":"2023","unstructured":"Stegmayr B, Zuo L, Zadora W. Lipid and bone effects of heparin use during hemodialysis. Semin Nephrol. 2023;43(6):151480.","journal-title":"Semin Nephrol"},{"key":"8093_CR12","doi-asserted-by":"crossref","unstructured":"Tran HA, Merriman E, Baker R, Curnow J, Young L, Tan CW, et al. 2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management. Intern Med J. 2025;55(7):1174\u201383.","DOI":"10.1111\/imj.70103"},{"key":"8093_CR13","doi-asserted-by":"crossref","unstructured":"Stevens SM, Woller SC, Baumann Kreuziger L, Doerschug K, Geersing G, Klok FA, et al. Antithrombotic therapy for VTE disease: compendium and review of CHEST Guidelines 2012\u20132021. Chest. 2024;166(2):388\u2013404.","DOI":"10.1016\/j.chest.2024.03.003"},{"key":"8093_CR14","doi-asserted-by":"crossref","unstructured":"Zhang Y, Guo S, Xu J. Multifunctional applications and research advances of low-molecular-weight heparin. Front Pharmacol. 2025;16:1585762.","DOI":"10.3389\/fphar.2025.1585762"},{"issue":"1","key":"8093_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00774-021-01268-5","volume":"2022\/1","author":"Y Li","year":"2022","unstructured":"Li Y, Liu L, Li S, Sun H, Zhang Y, Duan Z, et al. Impaired bone healing by enoxaparin via inhibiting the differentiation of bone marrow mesenchymal stem cells towards osteoblasts. J Bone Min Metab. 2022;40(1):9\u201319.","journal-title":"J Bone Min Metab"},{"key":"8093_CR16","doi-asserted-by":"crossref","unstructured":"Yang S, Niu Q, Gan L, Zhang X, Tu L, Zuo L. Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients. Hemodialysis international. International Symposium on Home Hemodialysis. 2020;24(3):374\u2009\u2013\u200982.","DOI":"10.1111\/hdi.12854"},{"issue":"2\/4","key":"8093_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.7150\/ijms.39523","volume":"2020","author":"S Yokoyama","year":"2020","unstructured":"Yokoyama S, Ieda S, Nagano M, Nakagawa C, Iwase M, Hosomi K, et al. Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach. Int J Med Sci. 2020;17(4):471\u20139.","journal-title":"Int J Med Sci"},{"key":"8093_CR18","doi-asserted-by":"crossref","unstructured":"Luo J, Li L, Shi W, Xu K, Shen Y, Dai B. Oxidative stress and inflammation: roles in osteoporosis. Front Immunol. 2025;16:1611932.","DOI":"10.3389\/fimmu.2025.1611932"},{"key":"8093_CR19","doi-asserted-by":"crossref","unstructured":"Iantomasi T, Romagnoli C, Palmini G, Donati S, Falsetti I, Miglietta F, et al. Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci. 2023;24(4):3772.","DOI":"10.3390\/ijms24043772"},{"issue":"1","key":"8093_CR20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00774-021-01290-7","volume":"2022\/3","author":"Y Mori","year":"2022","unstructured":"Mori Y, Aizawa T. Impacts of low molecular weight heparin on bone healing and osseointegration. J Bone Min Metab. 2022;40(2):357.","journal-title":"J Bone Min Metab"},{"key":"8093_CR21","doi-asserted-by":"crossref","unstructured":"Parums DV. A review of the importance and relevance of real-world data and real-world evidence. Med Sci Monit Int Med J experimental Clin Res. 2025;31:e951118.","DOI":"10.12659\/MSM.951118"},{"key":"8093_CR22","doi-asserted-by":"crossref","unstructured":"Kumar R, Romano JD, Ritchie MD. Network-based analyses of multiomics data in biomedicine. Biodata Min. 2025;18(1):37.","DOI":"10.1186\/s13040-025-00452-x"},{"issue":"1","key":"8093_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/1061186X.2024.2347358","volume":"2024\/7","author":"S Ahmad","year":"2024","unstructured":"Ahmad S, Raza K. An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives. J Drug Target. 2024;32(6):635\u201346.","journal-title":"J Drug Target"},{"key":"8093_CR24","doi-asserted-by":"crossref","unstructured":"Shen X, Zeng Z, Xie L, Yue X, Wang Z. Using weighted gene co-expression network analysis to identify key genes related to preeclampsia. Front Immunol. 2025;16:1569591.","DOI":"10.3389\/fimmu.2025.1569591"},{"key":"8093_CR25","doi-asserted-by":"crossref","unstructured":"Kanapari A, Lorenzoni G, Ocagli H, Gregori D. Current applications and future challenges of machine learning and artificial intelligence in clinical trials: a scoping review. Digit Health. 2025;11:610036984.","DOI":"10.1177\/20552076251393272"},{"key":"8093_CR26","doi-asserted-by":"crossref","unstructured":"Wang C, Wang X, Deng Y, Hu Y, Hu L. Network toxicology combined with molecular docking technology to explore the molecular mechanism of amatoxin causing liver injury. Sci Rep-UK. 2025;15(1):26068.","DOI":"10.1038\/s41598-025-11720-5"},{"key":"8093_CR27","unstructured":"Riaz AA, Ginimol M, Rasha R, Ahmed K, Ahmed A, Catrin S, et al. Transparency in the reporting of artificial intelligence: the Titan guideline. Premier J Sci. 2025;2."},{"issue":"3","key":"8093_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"2023\/1","author":"AEW Johnson","year":"2023","unstructured":"Johnson AEW, Bulgarelli L, Shen L, Gayles A, Shammout A, Horng S, et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1.","journal-title":"Sci Data"},{"key":"8093_CR29","doi-asserted-by":"crossref","unstructured":"Reis Romualdo G, Soares Pinhati ME, Andrade Souza R\u00ca, Lage Neves G, Batista C\u00e2ndido E, Lopes Da Silva Filho A. Efficacy of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after gynecological cancer surgery: A systematic review and meta-analysis. Eur J Surg oncology: J Eur Soc Surg Oncol Br Association Surg Oncol. 2025;51(6):109649.","DOI":"10.1016\/j.ejso.2025.109649"},{"key":"8093_CR30","doi-asserted-by":"crossref","unstructured":"Apostu D, Berechet B, Oltean-Dan D, Mester A, Petrushev B, Popa C, et al. Low-molecular-weight heparins (LMWH) and synthetic factor X inhibitors can impair the osseointegration process of a titanium implant in an interventional animal study. Medicina (Kaunas, Lithuania). 2022;58(11):1590.","DOI":"10.3390\/medicina58111590"},{"issue":"5\/1","key":"8093_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","volume":"2023","author":"A Falanga","year":"2023","unstructured":"Falanga A, Ay C, Di Nisio M, Gerotziafas G, Jara-Palomares L, Langer F, et al. Venous thromboembolism in cancer patients: ESMO clinical practice guideline. Ann Oncol: Official J Eur Soc Med Oncol. 2023;34(5):452\u201367.","journal-title":"Annals oncology: official J Eur Soc Med Oncol"},{"key":"8093_CR32","doi-asserted-by":"crossref","unstructured":"Noureldin A, Ivankovic V, Delisle M, Wang TF, Auer RC, Carrier M. Extended-duration thromboprophylaxis following major abdominopelvic surgery - For everyone or selected cases only? Thromb Res. 2024;235:175\u2009\u2013\u200980.","DOI":"10.1016\/j.thromres.2024.01.026"},{"issue":"1","key":"8093_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.apsb.2017.11.005","volume":"2018\/1","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Sun T, Jiang C. Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharm Sinica B. 2018;8(1):34\u201350.","journal-title":"Acta Pharm Sinica B"},{"key":"8093_CR34","doi-asserted-by":"crossref","unstructured":"Piazza G, Krishnathasan D, Hamade N, Ujueta F, Scimeca G, Ortiz-Rios MD, et al. Superficial vein thrombosis: a review. JAMA-J Am Med Assoc. 2025;334(22):2020\u201330.","DOI":"10.1001\/jama.2025.15222"},{"key":"8093_CR35","doi-asserted-by":"crossref","unstructured":"Monreal M, Brenner B, G\u00f3mez-Cuervo C, Dally N, Alda-Lozano A, Pesce ML, et al. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: a real-world cohort study from RIETE. Res Pract Thromb Hae. 2025;9(8):103244.","DOI":"10.1016\/j.rpth.2025.103244"},{"key":"8093_CR36","doi-asserted-by":"crossref","unstructured":"Chen Y, Ding Z, Lin T, Chen C, Liu Q, Liu M, et al. Association between enoxaparin administration and ICU 28-day mortality in sepsis patients: a comparative study. Resp Med. 2026;251:108543.","DOI":"10.1016\/j.rmed.2025.108543"},{"key":"8093_CR37","doi-asserted-by":"crossref","unstructured":"Gajic-Veljanoski O, Phua CW, Shah PS, Cheung AM. Effects of long-term low-molecular-weight heparin on fractures and bone density in non-pregnant adults: a systematic review with meta-analysis. J Gen Intern Med 2016;31(8):947\u201357.","DOI":"10.1007\/s11606-016-3603-8"},{"key":"8093_CR38","doi-asserted-by":"crossref","unstructured":"Jakonyte A, Gustainyte E, Petronis Z, Hafizov A, Janovskiene A, Razukevicius D. Risk of osteonecrosis of the jaw in patients treated with zoledronic or alendronic acid: a systematic review. Medicina (Kaunas, Lithuania). 2025;61(7):1159.","DOI":"10.3390\/medicina61071159"},{"key":"8093_CR39","doi-asserted-by":"crossref","unstructured":"Chen L, Tang J, Zhang L, Zheng L, Wang F, Guo F, et al. Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning. Front Pharmacol. 2025;16:1516013.","DOI":"10.3389\/fphar.2025.1516013"},{"issue":"4\/1804","key":"8093_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.jhep.2023.12.001","volume":"2024","author":"TC Yip","year":"2024","unstructured":"Yip TC, Lai JC, Yam T, Tse Y, Hui VW, Lai MS, et al. Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B. J Hepatol. 2024;80(4):553\u201363.","journal-title":"J Hepatol"},{"key":"8093_CR41","doi-asserted-by":"crossref","unstructured":"Huang P, Chiu SY, Chang K, Tseng P, Yen Y, Tsai M, et al. A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir. Hepatol Int. 2021;15(2):310\u20137.","DOI":"10.1007\/s12072-021-10148-z"},{"key":"8093_CR42","doi-asserted-by":"crossref","unstructured":"Soldado-Folgado J, Rins-Lozano O, Arrieta-Aldea I, Gonz\u00e1le-Mena A, Ca\u00f1as-Ruano E, Knobel H et al. Changes in bone quality after switching from a TDF to a TAF based ART: A pilot randomized study. Front Endocrinol. 2023;14:1076739.","DOI":"10.3389\/fendo.2023.1076739"},{"key":"8093_CR43","doi-asserted-by":"crossref","unstructured":"Black DM, Condra K, Adams AL, Eastell R. Bisphosphonates and the risk of atypical femur fractures. Bone. 2022;156:116297.","DOI":"10.1016\/j.bone.2021.116297"},{"key":"8093_CR44","doi-asserted-by":"crossref","unstructured":"Yang H, Liu M, Yin W, Zhou L, Zuo X. Safety and efficacy of low molecular weight heparin for thromboprophylaxis in the elderly: a network meta-analysis of randomized clinical trials. Front Pharmacol. 2021;12:783104.","DOI":"10.3389\/fphar.2021.783104"},{"issue":"1","key":"8093_CR45","doi-asserted-by":"publisher","first-page":"ITC1","DOI":"10.7326\/AITC202401160","volume":"2024","author":"KE Ensrud","year":"2024","unstructured":"Ensrud KE, Crandall CJ, Osteoporosis. Ann Intern Med. 2024;177(1):ITC1\u201316.","journal-title":"Ann Intern Med"},{"key":"8093_CR46","doi-asserted-by":"crossref","unstructured":"Department of Error. Lancet (London, England). 2022;400(10354):732.","DOI":"10.1016\/S0140-6736(22)01644-0"},{"issue":"2\/1176","key":"8093_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/M22-0684","volume":"2023","author":"C Ayers","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American college of physicians. Ann Intern Med. 2023;176(2):182\u201395.","journal-title":"Ann Intern Med"},{"issue":"1","key":"8093_CR48","first-page":"1881","volume":"2021\/10","author":"SE Noel","year":"2021","unstructured":"Noel SE, Santos MP, Wright NC. Racial and ethnic disparities in bone health and outcomes in the United States. J Bone Miner Res. 2021;36(10):1881\u2013905.","journal-title":"J bone mineral research: official J Am Soc Bone Mineral Res"},{"key":"8093_CR49","doi-asserted-by":"crossref","unstructured":"Chandran M, Akesson KE, Javaid MK, Harvey N, Blank RD, Brandi ML, et al. Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2024;35(8):1337\u201358.","DOI":"10.1007\/s00198-024-07059-8"},{"issue":"2\/1","key":"8093_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamasurg.2017.3787","volume":"2018","author":"CA Karcutskie","year":"2018","unstructured":"Karcutskie CA, Dharmaraja A, Patel J, Eidelson SA, Padiadpu AB, Martin AG, et al. Association of anti-factor Xa-guided dosing of enoxaparin with venous thromboembolism after trauma. JAMA Surg. 2018;153(2):144\u20139.","journal-title":"JAMA Surg"},{"key":"8093_CR51","doi-asserted-by":"crossref","unstructured":"Al Khzem AH, Ahmad S. Integrative computational approaches identify haptoglobin inhibitors to modulate erythrocyte sedimentation rate in trauma-linked inflammatory and haematological malignancies. Front Chem. 2025;13:1611972.","DOI":"10.3389\/fchem.2025.1611972"},{"key":"8093_CR52","doi-asserted-by":"crossref","unstructured":"Xu Y, Yuan B, Zhang M. Unraveling the molecular mechanisms of air pollution-induced lung adenocarcinoma through machine learning, network toxicology, and molecular docking. Biochem Bioph Res Co. 2026;797:153173.","DOI":"10.1016\/j.bbrc.2025.153173"},{"key":"8093_CR53","doi-asserted-by":"crossref","unstructured":"Arnold KM, Capuzzi SJ, Xu Y, Muratov EN, Carrick K, Szajek AY, et al. Modernization of enoxaparin molecular weight determination using homogeneous standards. Pharmaceuticals (Basel). 2017;10(3):66.","DOI":"10.3390\/ph10030066"},{"key":"8093_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fmolb.2021.639666","volume":"8","author":"D Shi","year":"2021","unstructured":"Shi D, Sheng A, Chi L. Glycosaminoglycan-protein interactions and their roles in human disease. Front Mol Biosci. 2021;8:15.","journal-title":"Front Mol Biosci"},{"key":"8093_CR55","doi-asserted-by":"crossref","unstructured":"Ahmad S, Raza K. Evaluating the polypharmacological potential of cosmetic preservative imidurea against lung cancer-associated EGFR, CDK2, STAT3, BCL2, p53, and ABCB1 proteins. Int J Biol Macromol. 2025;321:19.","DOI":"10.1016\/j.ijbiomac.2025.146175"},{"key":"8093_CR56","doi-asserted-by":"crossref","unstructured":"Dixon-Clarke SE, Shehata SN, Krojer T, Sharpe TD, von Delft F, Sakamoto K, et al. Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16. Biochem J. 2017;474(5):699\u2013713.","DOI":"10.1042\/BCJ20160941"},{"key":"8093_CR57","doi-asserted-by":"crossref","unstructured":"Xu H, Xu N, Wang Y, Zou H, Wu S. A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database. Front Pharmacol. 2024;15:1442002.","DOI":"10.3389\/fphar.2024.1442002"},{"key":"8093_CR58","doi-asserted-by":"crossref","unstructured":"Li D, Zhao Z, Zhu L, Feng H, Song J, Fu J, et al. 7,8-DHF inhibits BMSC oxidative stress via the TRKB\/PI3K\/AKT\/NRF2 pathway to improve symptoms of postmenopausal osteoporosis. Free Radic Biol Med. 2024;223:413\u2009\u2013\u200929.","DOI":"10.1016\/j.freeradbiomed.2024.08.014"},{"key":"8093_CR59","doi-asserted-by":"crossref","unstructured":"Liu C, Zhang J, Ye Z, Luo J, Peng B, Wang Z. Research on the role and mechanism of the PI3K\/Akt\/mTOR signalling pathway in osteoporosis. Front Endocrinol. 2025;16:1541714.","DOI":"10.3389\/fendo.2025.1541714"},{"issue":"39","key":"8093_CR60","doi-asserted-by":"publisher","first-page":"27105","DOI":"10.1074\/jbc.M114.576793","volume":"289","author":"N Artigas","year":"2014","unstructured":"Artigas N, Ure\u00f1a C, Rodr\u00edguez-Carballo E, Rosa JL, Ventura F. Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program. J Biol Chem. 2014;289(39):27105\u201317.","journal-title":"J Biol Chem"},{"key":"8093_CR61","doi-asserted-by":"crossref","unstructured":"Signorelli SS, Scuto S, Marino E, Giusti M, Xourafa A, Gaudio A. Anticoagulants and Osteoporosis. Int J Mol Sci. 2019;20(21):5275.","DOI":"10.3390\/ijms20215275"},{"key":"8093_CR62","doi-asserted-by":"crossref","unstructured":"Shen X, Yao Q, Ma L. Mechanisms responsible for the ability of enoxaparin sodium to inhibit inflammatory responses in the immune microenvironment of bone repair: A transcriptomic sequencing study. PLoS ONE. 2025;20(9):e332041.","DOI":"10.1371\/journal.pone.0332041"},{"key":"8093_CR63","doi-asserted-by":"crossref","unstructured":"Mendoza SV, Wells KV, Murugesh DK, Hum NR, Sebastian A, Gorman BM, et al. Osteocytic oxygen sensing: Distinct impacts of VHL and HIF-2alpha on bone integrity. Bone. 2025;192:117339.","DOI":"10.1016\/j.bone.2024.117339"},{"key":"8093_CR64","doi-asserted-by":"crossref","unstructured":"Chen K, Zhao J, Qiu M, Zhang L, Yang K, Chang L, et al. Osteocytic HIF-1\u03b1 pathway manipulates bone micro-structure and remodeling via regulating osteocyte terminal differentiation. Front Cell Dev Biol. 2022;9:721561.","DOI":"10.3389\/fcell.2021.721561"},{"key":"8093_CR65","doi-asserted-by":"crossref","unstructured":"Janeczko K, Agoro R. Oxygen sensing in osteocytes: from physiology to age-related osteoporosis. Curr Osteoporos Rep. 2025;23(1):28.","DOI":"10.1007\/s11914-025-00920-7"},{"issue":"22","key":"8093_CR66","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.3390\/cells11223552","volume":"11","author":"W Chen","year":"2022","unstructured":"Chen W, Wu P, Yu F, Luo G, Qing L, Tang J. HIF-1\u03b1 regulates bone homeostasis and angiogenesis, participating in the occurrence of bone metabolic diseases. Cells-Basel. 2022;11(22):3552.","journal-title":"Cells-Basel"},{"key":"8093_CR67","doi-asserted-by":"crossref","unstructured":"Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Investig. 2007;117(6):1616\u201326.","DOI":"10.1172\/JCI31581"},{"key":"8093_CR68","doi-asserted-by":"crossref","unstructured":"Knowles HJ. Hypoxic regulation of osteoclast differentiation and bone resorption activity. Hypoxia (Auckland, N.Z.). 2015;3:73\u201382.","DOI":"10.2147\/HP.S95960"},{"key":"8093_CR69","doi-asserted-by":"crossref","unstructured":"Li L, Yu C, Huang H, Wu H, Chu C, Huang C, et al. Suppression of hypoxia-inducible factor 1\u03b1 by low-molecular-weight heparin mitigates ventilation-induced diaphragm dysfunction in a murine endotoxemia model. Int J Mol Sci. 2021;22(4):1702.","DOI":"10.3390\/ijms22041702"},{"key":"8093_CR70","doi-asserted-by":"crossref","unstructured":"Ahmad S, Raza K. DrLungker. A deep ensemble learning framework for predicting anti-lung cancer compound activity and validating multitarget potency through WaterMap, DFT, MD simulations, and MM-GBSA analysis. Adv Theor Simul. 2025;23.","DOI":"10.1002\/adts.202501550"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08093-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:30:11Z","timestamp":1778589011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8093"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08093-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8842742\/v1","asserted-by":"object"}]},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was based on publicly available anonymized MIMIC-IV data. Ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no competing interests related to the conduct of this study, the authorship, or the publication of this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"663"}}